These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11028688)

  • 1. Consequences of adolescent drug use on psychiatric disorders in early adulthood.
    Brook JS; Richter L; Rubenstone E
    Ann Med; 2000 Sep; 32(6):401-7. PubMed ID: 11028688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent substance use disorders and comorbidity.
    Simkin DR
    Pediatr Clin North Am; 2002 Apr; 49(2):463-77. PubMed ID: 11993293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavioral disorders and substance abuse in adolescents with mental retardation].
    Papachristou E; Anagnostopoulos D
    Psychiatriki; 2014; 25(2):139-50. PubMed ID: 25035183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Substance abuse in adolescents].
    Vignau J; Karila L
    Rev Prat; 2003 Jun; 53(12):1315-9. PubMed ID: 12920940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric Comorbidity and Complications.
    Mason MJ; Aplasca A; Morales-Theodore R; Zaharakis N; Linker J
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):521-32. PubMed ID: 27338972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug abuse and adolescence: neurobiology and psychiatric implications].
    Luciani A; Todini L; Majorana M; Orso L
    Clin Ter; 2012 Jul; 163(4):e243-53. PubMed ID: 23007831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity of substance abuse and other psychiatric disorders in adolescents.
    Bukstein OG; Brent DA; Kaminer Y
    Am J Psychiatry; 1989 Sep; 146(9):1131-41. PubMed ID: 2669535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of psychiatric comorbidity with substance abuse in adolescents: effects of timing and sex.
    Costello EJ; Erkanli A; Federman E; Angold A
    J Clin Child Psychol; 1999 Sep; 28(3):298-311. PubMed ID: 10446679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which measure of adolescent psychiatric disorder--diagnosis, number of symptoms, or adaptive functioning--best predicts adverse young adult outcomes?
    Vander Stoep A; Weiss NS; McKnight B; Beresford SA; Cohen P
    J Epidemiol Community Health; 2002 Jan; 56(1):56-65. PubMed ID: 11801621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of substance abuse in an adolescent psychiatric population.
    Roehrich H; Gold MS
    Int J Psychiatry Med; 1986-1987; 16(2):137-43. PubMed ID: 3744682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating adolescents for substance abuse and comorbid psychiatric disorders.
    Riggs PD
    Sci Pract Perspect; 2003 Aug; 2(1):18-29. PubMed ID: 18552718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Adolescent Community Reinforcement Approach (A-CRA) as a model paradigm for the management of adolescents with substance use disorders and co-occurring psychiatric disorders.
    Godley SH; Smith JE; Passetti LL; Subramaniam G
    Subst Abus; 2014; 35(4):352-63. PubMed ID: 25035906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA; Harris SK; Kurland M; Knight JR
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of smoking, drinking, and substance use and their relationship to psychiatric comorbidity in children and adolescents with depression].
    Kiss E; Pikó B; Vetró A
    Psychiatr Hung; 2006; 21(3):219-26. PubMed ID: 17090834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent important substance-related losses predict readiness to change scores among people with co-occurring psychiatric disorders.
    Blume AW; Marlatt GA
    Addict Behav; 2000; 25(3):461-4. PubMed ID: 10890302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Comorbidity of Psychiatric and Substance Use Disorders Among Hispanic Adolescents.
    Gattamorta KA; Mena MP; Ainsley JB; Santisteban DA
    J Dual Diagn; 2017; 13(4):254-263. PubMed ID: 28661822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal study of co-occurring psychiatric disorders and substance use.
    Brook JS; Cohen P; Brook DW
    J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):322-30. PubMed ID: 9519638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adolescents who have tried illicit drugs and experienced psychiatric symptoms seldom seek professional help. A pilot study of 18-year old high school students in an urban district].
    Gunnarsson M; Fahlke C; Balldin J
    Lakartidningen; 2004 Apr; 101(14):1280-2. PubMed ID: 15101214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.